Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma

C

Chonbuk National University

Status

Completed

Conditions

Lymphoma, Large B-cell, Diffuse

Study type

Observational

Funder types

Other

Identifiers

NCT02555267
GERIAD

Details and patient eligibility

About

This study investigate the impact of comprehensive geriatric assessments using activity of daily living (ADL), instrumental activity of daily living (IADL), and Charlson's comorbidity index (CCI) on survival and toxicities in Korean patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP.

Enrollment

148 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with newly diagnosed CD20+ DLBCL
  • 65 years old or over
  • Scheduled to receive R-CHOP chemotherapy
  • Informed consent

Exclusion criteria

  • Other histology than CD20+ DLBCL
  • Primary central nervous system DLBCL
  • Patients with a diagnosis of cancer (other than basal or squamous cell carcinoma of the skin, cervical carcinoma in situ, well differentiated thyroid cancer [papillary or follicular thyroid cancer]) within 3 years before the study entry or with any treatment for cancer within 3 years before entry
  • Consent withdrawal

Trial design

148 participants in 1 patient group

Elderly patients with DLBCL
Description:
Elderly patients (age>=65 years) with DLBCL treated with R-CHOP chemotherapy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems